AI Drug Discovery for Pharma and Biotech

Drug discovery

6

papers

On emerging therapies

Overview

Tetrasomy 18p is a rare chromosomal disorder caused by a supernumerary isochromosome 18p, resulting in four copies of the short arm of chromosome 18. Clinically, it presents with feeding difficulties, developmental delays, mild-to-moderate intellectual disability (rarely severe), hypotonia/hypertonia, distinctive facial features (low-set ears, micrognathia, thin upper lip), congenital anomalies (palatal defects, cardiac/renal malformations), and comorbidities such as seizures, hearing/vision issues, and gastrointestinal dysfunction. Phenotypic variability is significant [1][2][6][12].

Population

  • Affects ~250 families globally, with equal gender distribution. Most cases arise de novo; rare familial instances involve parental mosaicism or rearrangements [2][6][18].

Burden

  • Lifelong developmental delays (average IQ ~48), behavioral challenges (ADHD, anxiety), and frequent medical comorbidities. While life expectancy is near-normal, quality of life is impacted by chronic care needs and psychosocial stressors [6][15][18].

Therapies

  • Multidisciplinary care: Early developmental interventions (PT/OT/speech), endocrine management (growth hormone deficiency), GI support (feeding tubes, reflux management), and neurologic monitoring (seizures) [3][12][14].

  • Surgical/medical management: Correction of congenital anomalies (cardiac defects, cleft palate), orthopedic interventions (scoliosis, foot abnormalities) [4][12][18].

Categories: rare developmental anomalies during embryogenesis, rare genetic diseases

Research Papers

6 drug discovery papers about Tetrasomy 18p. Recent publications:

6 drug discovery papers about Tetrasomy 18p. Recent publications:

categories:

Small molecules

gene therapies
2026-02-09 | A rare case of mosaic partial tetrasomy 18p presenting with oligomenorrhea and intellectual disability: a case report.

Tetrasomy 18p syndrome is an extremely rare chromosomal disorder that is often the result of an additional isochromosome for the short arm of chromosome 18. Most cases result from de novo mutations, although familial cases have also been reported. In this article, we report for the first time a case of a 17-year-old female patient with mosaic tetrasomy 18p. This study aimed to investigate the genetic and clinical characteristics of patients with tetrasomy 18p and to enhance the understanding of tetrasomy 18p. A female patient presenting with oligomenorrhea, distinctive physical features, and intellectual disability underwent chromosomal karyotype analysis via G-, C-, and N-banding techniques. Upon the detection of abnormal results, high-throughput genomic copy number variation sequencing (CNV-seq) was performed to establish a definitive diagnosis. Additionally, chromosomal karyotype analysis was conducted on both parents and the patient's three younger sisters. The G-banding karyotype results indicated 47,XX,+mar[85]/46,XX[15], suggesting a mosaic condition with one additional marker chromosome. C-banding revealed one centromere on the small marker chromosome, whereas N-banding revealed no satellite. CNV-seq analysis revealed a 14.86 Mb mosaic duplication spanning 18p11.32-p11.21, with an estimated copy number of 3.5. On the basis of these findings, the final chromosomal karyotype was designated 47,XX,+i(18)(p10)[85]/46,XX[15]. No chromosomal abnormalities were identified in the karyotypes of the patient's parents or three sisters, indicating that this is a de novo mutation. The patient's oligomenorrhea, distinctive features, and intellectual disability may be associated with a partial duplication of the short arm of chromosome 18. Previous reports on patients with tetrasomy 18p have focused primarily on preschool or prepubescent patients. Here, we present the first reported case of a 17-year-old female with mosaic tetrasomy 18p. The absence of fingerprints on the palms and oligomenorrhea may represent novel characteristics of this condition. For such rare chromosomal abnormalities, the combined use of G-banding, C-banding karyotype analysis, CNV-seq technology, and comprehensive clinical evaluation can facilitate early diagnosis, genetic counseling, and personalized treatment.

Open article ↗



2025-12-31 | Tetrasomy 18p Syndrome: A Rare Case with Congenital Hypoplasia of the Depressor Angularis Oris

Introduction: Tetrasomy 18p syndrome is an extremely rare chromosomal disorder where there are four copies of chromosome 18 instead of two due to the presence of isochromosome 18p. We aim to report a case of tetrasomy 18p with unusual phenotypic presentation with congenital hypoplasia of depressor angularis oris muscle. Case Report: We present a case of a neonatal boy with tetrasomy 18p syndrome, who was initially admitted for bilateral undescended testes. This syndrome has been found to have variability in its clinical features. The patient was found to have soft dysmorphic features, feeding difficulty, congenital hypoplasia of the depressor angularis oris muscle, growth retardation, hypotonia, and jaundice. During follow-up, he was found to have strabismus, hearing loss, failure to thrive, and global developmental delay. Conclusion: We compared the phenotypic characteristics of our case with previously reported cases of this syndrome. To the best of our knowledge, congenital hypoplasia of the depressor angularis oris has not been reported previously as a phenotypic characteristic of this syndrome and might be considered a diagnostic feature if more cases are reported in the future. Additionally, it is easy to miss such cases, as some neonates do not present with typical dysmorphic features that would prompt a karyotype analysis.

Open article ↗



gene therapies
2026-02-09 | A rare case of mosaic partial tetrasomy 18p presenting with oligomenorrhea and intellectual disability: a case report.

Tetrasomy 18p syndrome is an extremely rare chromosomal disorder that is often the result of an additional isochromosome for the short arm of chromosome 18. Most cases result from de novo mutations, although familial cases have also been reported. In this article, we report for the first time a case of a 17-year-old female patient with mosaic tetrasomy 18p. This study aimed to investigate the genetic and clinical characteristics of patients with tetrasomy 18p and to enhance the understanding of tetrasomy 18p. A female patient presenting with oligomenorrhea, distinctive physical features, and intellectual disability underwent chromosomal karyotype analysis via G-, C-, and N-banding techniques. Upon the detection of abnormal results, high-throughput genomic copy number variation sequencing (CNV-seq) was performed to establish a definitive diagnosis. Additionally, chromosomal karyotype analysis was conducted on both parents and the patient's three younger sisters. The G-banding karyotype results indicated 47,XX,+mar[85]/46,XX[15], suggesting a mosaic condition with one additional marker chromosome. C-banding revealed one centromere on the small marker chromosome, whereas N-banding revealed no satellite. CNV-seq analysis revealed a 14.86 Mb mosaic duplication spanning 18p11.32-p11.21, with an estimated copy number of 3.5. On the basis of these findings, the final chromosomal karyotype was designated 47,XX,+i(18)(p10)[85]/46,XX[15]. No chromosomal abnormalities were identified in the karyotypes of the patient's parents or three sisters, indicating that this is a de novo mutation. The patient's oligomenorrhea, distinctive features, and intellectual disability may be associated with a partial duplication of the short arm of chromosome 18. Previous reports on patients with tetrasomy 18p have focused primarily on preschool or prepubescent patients. Here, we present the first reported case of a 17-year-old female with mosaic tetrasomy 18p. The absence of fingerprints on the palms and oligomenorrhea may represent novel characteristics of this condition. For such rare chromosomal abnormalities, the combined use of G-banding, C-banding karyotype analysis, CNV-seq technology, and comprehensive clinical evaluation can facilitate early diagnosis, genetic counseling, and personalized treatment.

Open article ↗



2025-12-31 | Tetrasomy 18p Syndrome: A Rare Case with Congenital Hypoplasia of the Depressor Angularis Oris

Introduction: Tetrasomy 18p syndrome is an extremely rare chromosomal disorder where there are four copies of chromosome 18 instead of two due to the presence of isochromosome 18p. We aim to report a case of tetrasomy 18p with unusual phenotypic presentation with congenital hypoplasia of depressor angularis oris muscle. Case Report: We present a case of a neonatal boy with tetrasomy 18p syndrome, who was initially admitted for bilateral undescended testes. This syndrome has been found to have variability in its clinical features. The patient was found to have soft dysmorphic features, feeding difficulty, congenital hypoplasia of the depressor angularis oris muscle, growth retardation, hypotonia, and jaundice. During follow-up, he was found to have strabismus, hearing loss, failure to thrive, and global developmental delay. Conclusion: We compared the phenotypic characteristics of our case with previously reported cases of this syndrome. To the best of our knowledge, congenital hypoplasia of the depressor angularis oris has not been reported previously as a phenotypic characteristic of this syndrome and might be considered a diagnostic feature if more cases are reported in the future. Additionally, it is easy to miss such cases, as some neonates do not present with typical dysmorphic features that would prompt a karyotype analysis.

Open article ↗



Access all drug discovery papers and probability of success in trials forecasts:

Access all drug discovery papers and probability of success in trials forecasts:

Drug Discovery Landscape

0 orphan drug designations.

0 orphan drug designations.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.